169 related articles for article (PubMed ID: 34981697)
1. Infliximab rescue therapy in a patient with acute severe ulcerative colitis and coronavirus disease 2019 followed by Escherichia coli 0157:H7 infection: a case report.
Bekić D; Belošić Halle Ž
Croat Med J; 2021 Dec; 62(6):634-637. PubMed ID: 34981697
[TBL] [Abstract][Full Text] [Related]
2. SARS-CoV-2 (COVID-19) pneumonia patient treated with two doses of infliximab within 2 weeks for acute severe ulcerative colitis: A case report.
Alhalabi M; Eddin KA; Ali F; Abbas A
Medicine (Baltimore); 2022 Jan; 101(4):e28722. PubMed ID: 35089243
[TBL] [Abstract][Full Text] [Related]
3. Induction of remission with tacrolimus in a patient with severe acute, cortisone refractory ulcerative colitis and severe Covid-19 pneumonia: a case report.
Rieker L; Hofer J; Petzold G; Ellenrieder V; Amanzada A
BMC Gastroenterol; 2022 Jan; 22(1):22. PubMed ID: 35033015
[TBL] [Abstract][Full Text] [Related]
4. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
[TBL] [Abstract][Full Text] [Related]
5. Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion.
Ake JA; Jelacic S; Ciol MA; Watkins SL; Murray KF; Christie DL; Klein EJ; Tarr PI
Pediatrics; 2005 Jun; 115(6):e673-80. PubMed ID: 15930195
[TBL] [Abstract][Full Text] [Related]
6. Risk of hemolytic uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 enteritis: a meta-analysis.
Safdar N; Said A; Gangnon RE; Maki DG
JAMA; 2002 Aug; 288(8):996-1001. PubMed ID: 12190370
[TBL] [Abstract][Full Text] [Related]
7. An older patient with active ulcerative colitis and coronavirus disease 2019 (COVID-19) pneumonia successfully treated with the combination of anti-TNFα therapy and azathioprine.
Yamakawa T; Ishigami K; Ohwada S; Kazama T; Hirayama D; Yoshii S; Yamano HO; Nakase H
Clin J Gastroenterol; 2023 Apr; 16(2):187-192. PubMed ID: 36417106
[TBL] [Abstract][Full Text] [Related]
8. The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections.
Wong CS; Jelacic S; Habeeb RL; Watkins SL; Tarr PI
N Engl J Med; 2000 Jun; 342(26):1930-6. PubMed ID: 10874060
[TBL] [Abstract][Full Text] [Related]
9. Hypoalbuminemia and Bandemia Predict Failure of Infliximab Rescue Therapy in Acute Severe Ulcerative Colitis.
Syal G; Robbins L; Kashani A; Bonthala N; Feldman E; Fleshner P; Vasiliauskas E; McGovern D; Ha C; Targan S; Melmed GY
Dig Dis Sci; 2021 Jan; 66(1):199-205. PubMed ID: 32170473
[TBL] [Abstract][Full Text] [Related]
10. Intranasal immunization with novel EspA-Tir-M fusion protein induces protective immunity against enterohemorrhagic Escherichia coli O157:H7 challenge in mice.
Lin R; Zhu B; Zhang Y; Bai Y; Zhi F; Long B; Li Y; Wu Y; Wu X; Fan H
Microb Pathog; 2017 Apr; 105():19-24. PubMed ID: 28163157
[TBL] [Abstract][Full Text] [Related]
11. Hemolytic uremic syndrome: differential diagnosis with the onset of inflammatory bowel diseases.
Bianchi L; Gaiani F; Vincenzi F; Kayali S; Di Mario F; Leandro G; De' Angelis GL; Ruberto C
Acta Biomed; 2018 Dec; 89(9-S):153-157. PubMed ID: 30561409
[TBL] [Abstract][Full Text] [Related]
12. [Hemorrhagic colitis and hemolytic uremic syndrome caused by Escherichia coli O157:H7].
Attar A; Becheur H; Gilbert T; Bloch F; Petite JP
Ann Med Interne (Paris); 1998 Sep; 149(5):288-90. PubMed ID: 9791563
[TBL] [Abstract][Full Text] [Related]
13. Illnesses associated with Escherichia coli O157:H7 infections. A broad clinical spectrum.
Griffin PM; Ostroff SM; Tauxe RV; Greene KD; Wells JG; Lewis JH; Blake PA
Ann Intern Med; 1988 Nov; 109(9):705-12. PubMed ID: 3056169
[TBL] [Abstract][Full Text] [Related]
14. Antibacterial and immunomodulatory activities of bovine lactoferrin against Escherichia coli O157:H7 infections in cattle.
Kieckens E; Rybarczyk J; Cox E; Vanrompay D
Biometals; 2018 Jun; 31(3):321-330. PubMed ID: 29442205
[TBL] [Abstract][Full Text] [Related]
15. [Acute gastroenteritis caused by enterohemorrhagic E. coli O157:H7].
Weinberger T; Hayek T; Keidar S
Harefuah; 1998 May; 134(10):767-9, 831. PubMed ID: 10909634
[TBL] [Abstract][Full Text] [Related]
16. Three cases of hemorrhagic colitis in West Virginia due to Escherichia coli O157:H7.
Battle EH; Elliott SY
W V Med J; 1995; 91(7):320-1. PubMed ID: 8533400
[TBL] [Abstract][Full Text] [Related]
17. Discontinuation of infliximab in patients with ulcerative colitis in remission (HAYABUSA): a multicentre, open-label, randomised controlled trial.
Kobayashi T; Motoya S; Nakamura S; Yamamoto T; Nagahori M; Tanaka S; Hisamatsu T; Hirai F; Nakase H; Watanabe K; Matsumoto T; Tanaka M; Abe T; Suzuki Y; Watanabe M; Hibi T;
Lancet Gastroenterol Hepatol; 2021 Jun; 6(6):429-437. PubMed ID: 33887262
[TBL] [Abstract][Full Text] [Related]
18. Strength of the association between antibiotic use and hemolytic uremic syndrome following Escherichia coli O157:H7 infection varies with case definition.
Tarr GAM; Oltean HN; Phipps AI; Rabinowitz P; Tarr PI
Int J Med Microbiol; 2018 Oct; 308(7):921-926. PubMed ID: 30257808
[TBL] [Abstract][Full Text] [Related]
19. Risk of hemolytic uremic syndrome from antibiotic treatment of Escherichia coli O157:H7 colitis.
Tarr PI; Watkins SL; Neill MA
JAMA; 2002 Dec; 288(24):3111-2; author reply 3112. PubMed ID: 12495389
[No Abstract] [Full Text] [Related]
20. Risk of hemolytic uremic syndrome from antibiotic treatment of Escherichia coli O157:H7 colitis.
Wong CS; Brandt JR
JAMA; 2002 Dec; 288(24):3111; author reply 3112. PubMed ID: 12495388
[No Abstract] [Full Text] [Related]
[Next] [New Search]
